$0.84
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 1
Data gathered: December 1
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 0% |
|
| Sentiment | 25 0% |
|
| Webpage traffic | 12,000 -6.2% |
|
| Employee Rating | 86 0% |
|
| Google Trends | 0% |
|
| Linkedin Employees | 86 N/A |
|
| Patents | 17 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 0% |
|
| Facebook followers | 175 0% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 1,653 -0.1% |
|
| Twitter Followers | 462 0% |
|
| Youtube Subscribers | 44 0% |
|
| Instagram Followers | 186 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 79 0% |
|
In the news
 |
Kezar Life Sciences (NASDAQ:KZR) & Kamada (NASDAQ:KMDA) Financial ComparisonNovember 26 - ETF Daily News |
Analyst Expectations for Kezar Life Sciences's FutureNovember 26 - Benzinga |
|
Buy Rating Affirmed: Kezar Life Sciences’ Promising Trials and Strong FinancialsNovember 26 - TipRanks |
|
 |
Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNovember 21 - Yahoo |
Kezar Life Sciences GAAP EPS of -$0.32 beats by $0.04, revenue of $7M beats by $6.7MNovember 13 - Seeking Alpha |
|
Hold Rating for Kezar Life Sciences Amid Uncertainty: An Analysis of Management Changes, Drug Trials, and Financial ProspectsNovember 13 - TipRanks |
|
About Kezar Life Sciences
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
| Price | $0.84 |
| Target Price | Sign up |
| Market Cap | $60M |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 6.6M | 8.8M | -2.2M | -23M | -26M |
| Q2 '23 | 0 | 5.8M | -6.2M | -24M | -24M |
| Q1 '23 | 0 | 6.2M | -6.6M | -22M | -22M |
| Q4 '22 | 0 | 5.2M | -5.5M | -18M | -20M |
| Q3 '22 | 0 | 5.1M | -5.4M | -18M | -17M |
Insider Transactions
| Morningside Venture Investments Ltd filed to sell 5,447,993 shares at $6.9. February 7 '23 |
| Morningside Venture Investments Ltd filed to sell 5,512,993 shares at $7.2. February 3 '23 |
| Morningside Venture Investments Ltd filed to sell 5,602,993 shares at $7.1. February 1 '23 |
| Morningside Venture Investments Ltd filed to sell 5,662,993 shares at $6.9. January 27 '23 |
| Morningside Venture Investments Ltd filed to sell 5,712,993 shares at $7. January 25 '23 |
Read more about Kezar Life Sciences and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.